Can gene therapy restore sight by targeting the brain's critical development window?

Treating Blindness With Light (and Gene Therapy) | SciShow News · 6:21 · Video: SciShow · Watch at the source

In short: For children with Leber’s Congenital Amaurosis, the darkness isn't just a lack of light; it is a biological deficit. New evidence suggests that using gene therapy to fix a protein deficiency during childhood can actually strengthen the brain's visual pathways before they lose the ability to process sight.

Leber’s Congenital Amaurosis (LCA) is a rare genetic condition caused by mutations in genes like RPE 65. This mutation prevents retinal cells from producing a protein essential for normal vision. For children like Saffie Sandford, the condition manifests as poor sight in daylight and a total lack of vision in low light. Without intervention, the condition typically progresses until the patient is completely blind by age 30.

A breakthrough treatment called Luxturna (Voretigene Neparvovec) has provided a new way to combat this retinal dystrophy. By delivering a functional version of the gene, the therapy addresses the underlying protein deficiency. Recent research from UCL and Great Ormond Street Hospital (GOSH) highlights a vital nuance: timing is everything. Treating children during critical stages of brain development can do more than just fix the eye; it can strengthen the neural pathways required for sight.

In a significant UK study, researchers followed 15 children treated at GOSH between 2020 and 2023. The results suggest that early intervention can be life-changing, allowing patients to perform tasks that were previously impossible, such as navigating in the dark. This research marks a major milestone, representing the first published example of using gene therapy to restore vision in a patient.

While the success stories are profound, the medical community continues to study how these treatments interact with the developing nervous system. The ability to intervene before the brain's visual processing capabilities atrophy represents a major shift in how we approach inherited blindness.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-treating-blindness-with-light-and-gene-therapy-scishow-news.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…